Axel Ullrich

7.4k total citations · 4 hit papers
55 papers, 6.1k citations indexed

About

Axel Ullrich is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Axel Ullrich has authored 55 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 15 papers in Oncology and 11 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Axel Ullrich's work include HER2/EGFR in Cancer Research (9 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Glycosylation and Glycoproteins Research (6 papers). Axel Ullrich is often cited by papers focused on HER2/EGFR in Cancer Research (9 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Glycosylation and Glycoproteins Research (6 papers). Axel Ullrich collaborates with scholars based in Germany, United States and Austria. Axel Ullrich's co-authors include Klaus Strebhardt, Karl H. Plate, B Millauer, Laura K. Shawver, Joseph Schlessinger, Robert M. Hudziak, Gary M. Clark, Amol Tandon, Gary C. Chamness and Oliver Hobert and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Axel Ullrich

54 papers receiving 5.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant

1994 1.0k citations B Millauer, Laura K. Shawver et al. Nature profile →
Paul Ehrlich's magic bullet concept: 100 years of progress

2008 954 citations Klaus Strebhardt, Axel Ullrich Nature reviews. Cancer profile →
Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells.

1987 541 citations Axel Ullrich et al. profile →
HER-2/neu oncogene protein and prognosis in breast cancer.

1989 497 citations Axel Ullrich et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Axel Ullrich Germany	27	3.7k	2.2k	1.2k	1.1k	704	55	6.1k
Sara Lavi Israel	38	4.4k 1.2×	3.2k 1.4×	1.6k 1.3×	783 0.7×	582 0.8×	72	6.7k
Alan F. Wahl United States	36	3.1k 0.8×	3.3k 1.5×	2.0k 1.6×	576 0.5×	1.1k 1.5×	64	6.9k
E. L. V. Mayes United Kingdom	11	3.4k 0.9×	2.2k 1.0×	1.5k 1.2×	387 0.4×	565 0.8×	17	5.2k
Ralph Schwall United States	48	6.1k 1.6×	2.7k 1.2×	1.4k 1.2×	1.2k 1.1×	1.4k 2.0×	85	10.2k
Richard N. Harkins United States	30	3.8k 1.0×	1.3k 0.6×	594 0.5×	925 0.9×	1.2k 1.8×	58	7.4k
Paule Opolon France	44	3.5k 0.9×	1.5k 0.7×	564 0.5×	1.3k 1.2×	1.1k 1.6×	159	6.6k
Janet E. Price United States	48	3.7k 1.0×	3.2k 1.4×	548 0.4×	1.5k 1.4×	1.0k 1.4×	136	7.5k
Silvana Canevari Italy	49	4.4k 1.2×	3.2k 1.4×	1.9k 1.5×	1.4k 1.3×	2.2k 3.2×	227	8.7k
Gerhard Moldenhauer Germany	52	3.4k 0.9×	2.7k 1.2×	1.8k 1.5×	860 0.8×	2.9k 4.1×	129	7.6k
Timothy P. Fleming United States	45	4.8k 1.3×	3.0k 1.3×	728 0.6×	1.4k 1.3×	1.1k 1.6×	120	8.0k

Countries citing papers authored by Axel Ullrich

Since Specialization

Citations

This map shows the geographic impact of Axel Ullrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Axel Ullrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Axel Ullrich more than expected).

Fields of papers citing papers by Axel Ullrich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Axel Ullrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Axel Ullrich. The network helps show where Axel Ullrich may publish in the future.

Co-authorship network of co-authors of Axel Ullrich

This figure shows the co-authorship network connecting the top 25 collaborators of Axel Ullrich. A scholar is included among the top collaborators of Axel Ullrich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Axel Ullrich. Axel Ullrich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ullrich, Axel, et al.. (2016). WHO struggle against childhood cancer. Russian Journal of Pediatric Hematology and Oncology. 3(4). 56–59. 1 indexed citations

Kaneta, Yasuyuki & Axel Ullrich. (2013). NEK9 depletion induces catastrophic mitosis by impairment of mitotic checkpoint control and spindle dynamics. Biochemical and Biophysical Research Communications. 442(3-4). 139–146. 27 indexed citations

Oak, Prajakta, Florian Kopp, Chitra Thakur, et al.. (2012). Combinatorial treatment of mammospheres with trastuzumab and salinomycin efficiently targets HER2‐positive cancer cells and cancer stem cells. International Journal of Cancer. 131(12). 2808–2819. 64 indexed citations

Strebhardt, Klaus & Axel Ullrich. (2008). Paul Ehrlich's magic bullet concept: 100 years of progress. Nature reviews. Cancer. 8(6). 473–480. 954 indexed citations breakdown →

Wu, Yuanyuan, Zhi Chen, & Axel Ullrich. (2003). EGFR and FGFR Signaling through FRS2 Is Subject to Negative Feedback Control by ERK1/2. Biological Chemistry. 384(8). 1215–26. 39 indexed citations

Su, I-hsin, Ashwin Basavaraj, Andrew N. Krutchinsky, et al.. (2002). Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement. Nature Immunology. 4(2). 124–131. 481 indexed citations

Wu, Chuan-Jin, Zhengjun Chen, Axel Ullrich, Mark I. Greene, & Donald M. O’Rourke. (2000). Inhibition of EGFR-mediated phosphoinositide-3-OH kinase (PI3-K) signaling and glioblastoma phenotype by Signal-Regulatory Proteins (SIRPs). Oncogene. 19(35). 3999–4010. 58 indexed citations

Campiglio, Manuela, Suhad Ali, Piotr G. Knyazev, & Axel Ullrich. (1999). Characteristics of EGFR family-mediated HRG signals in human ovarian cancer. Journal of Cellular Biochemistry. 73(4). 522–532. 45 indexed citations

Shawver, Laura K., Laurie M. Strawn, & Axel Ullrich. (1995). Membrane bound receptor tyrosine kinases and chemical carcinogenesis. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 333(1-2). 23–28. 5 indexed citations

10.

Iacobelli, Stefano, Axel Ullrich, Nicola Tinari, et al.. (1995). The 90K Tumor-Associated Antigen and Clinical Progression in Human Immunodeficiency Virus Infection. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 10(4). 450–456. 16 indexed citations

11.

Millauer, B, et al.. (1994). Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature. 367(6463). 576–579. 1036 indexed citations breakdown →

12.

Bacus, S S, Ilana Stancovski, Eliezer Huberman, et al.. (1992). Tumor-inhibitory monoclonal antibodies to the HER-2/Neu receptor induce differentiation of human breast cancer cells.. PubMed. 52(9). 2580–9. 97 indexed citations

13.

Sarup, Jay, R. M. Johnson, K. L. King, et al.. (1991). Characterization of an anti-p185HER2 monoclonal antibody that stimulates receptor function and inhibits tumor cell growth.. PubMed. 1(2). 72–82. 142 indexed citations

14.

Giovanella, Beppino C., Leo J. Williams, D. Jane Taylor, et al.. (1991). Heterotransplantation of human breast carcinomas in nude mice. Correlation between successful heterotransplants, poor prognosis and amplification of the her‐2/neu oncogene. International Journal of Cancer. 47(1). 66–71. 50 indexed citations

15.

Levy, J, Axel Ullrich, & Jerrold M. Olefsky. (1988). Endocytotic uptake, processing, and retroendocytosis of human biosynthetic proinsulin by rat fibroblasts transfected with the human insulin receptor gene.. Journal of Clinical Investigation. 81(5). 1370–1377. 12 indexed citations

16.

Formby, Bent, Axel Ullrich, Lisa M. Coussens, Liberty Walker, & Charles M. Peterson. (1988). Growth Hormone Stimulates Insulin Gene Expression in Cultured Human Fetal Pancreatic Islets*. The Journal of Clinical Endocrinology & Metabolism. 66(5). 1075–1079. 32 indexed citations

17.

Ullrich, Axel, Roy H. Steinberg, P. Baierl, & G. ten Bruggencate. (1982). Changes in extracellular potassium and calcium in rat cerebellar cortex related to local inhibition of the sodium pump. Pflügers Archiv - European Journal of Physiology. 395(2). 108–114. 17 indexed citations

18.

Brosius, Jürgen, Axel Ullrich, Alane Gray, et al.. (1981). Construction and fine mapping of recombinant plasmids containing the rrnB ribosomal RNA operon of E. coli. Plasmid. 6(1). 112–118. 425 indexed citations

19.

Ullrich, Axel, P. Baierl, & G. ten Bruggencate. (1980). Extracellular potassium in rat cerebellar cortex during acute and chronic lithium application. Brain Research. 192(1). 287–290. 23 indexed citations

20.

Richards, Robert I., John Shine, Axel Ullrich, J. R. E. Wells, & Howard M. Goodman. (1979). Molecular cloning and sequence analysis of adult chicken β globin cDNA. Nucleic Acids Research. 7(5). 1137–1146. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact